Author: Samara Khan

Samara is a public health professional in NYC with a background in epidemiology and neuroscience and social services. She is a passionate about public health research.

One company’s approach to breaking barriers within the TME to overcome recalcitrant cancers. Earlier this month, a preview of patient-derived biomarkers and preclinical data that demonstrates strong potential in treating patients with immune-excluded tumors such as colorectal, ovarian, pancreatic, triple negative breast cancer and non-small cell lung cancer was presented at the Stifel Healthcare Conference in New York. Parthenon Therapeutics showcased this evidence and anticipate its first in human clinical trials of their lead asset to begin in the latter half of 2023. In late 2021, the company announced the publication of a manuscript in the prestigious peer-reviewed journal Nature.…

Read More